0.7993
0.0223 (2.87%)
0.0223 (2.87%)
Upgrade to Real-Time
Regular Market
| Volume | 186,844 |
|
|||||
| News | - | ||||||
| Day High | 0.82 | Low High |
|||||
| Day Low | 0.76 | ||||||
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Lipocine Inc | LPCN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| 0.0223 | 2.87% | 0.7993 | 14:56:16 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.7844 | 0.76 | 0.82 | 0.777 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 530 | 186,844 | $ 0.7841038 | $ 146,505 | - | 0.708 - 1.89 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:00:47 | 95 | $ 0.7993 | USD |
Period:
Draw Mode:
Lipocine Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 70.74M | 88.50M | 86.21M | $ 16.14M | $ -747.32k | -0.01 | -77.70 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 287.50k | 3.50% |
Lipocine News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LPCN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.83 | 0.8876 | 0.708 | 0.7635942 | 363,595 | -0.0307 | -3.7% |
| 1 Month | 1.04 | 1.11 | 0.708 | 0.9095166 | 477,493 | -0.2407 | -23.14% |
| 3 Months | 1.2346 | 1.89 | 0.708 | 1.36 | 902,394 | -0.4353 | -35.26% |
| 6 Months | 1.20 | 1.89 | 0.708 | 1.24 | 694,322 | -0.4007 | -33.39% |
| 1 Year | 1.28 | 1.89 | 0.708 | 1.26 | 785,243 | -0.4807 | -37.55% |
| 3 Years | 1.88 | 3.50 | 0.301 | 1.43 | 1,530,378 | -1.08 | -57.48% |
| 5 Years | 3.71 | 5.33 | 0.301 | 1.56 | 1,059,520 | -2.91 | -78.46% |
Lipocine Description
| Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO, is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107. |